CDK2 and hepatocellular carcinoma: To understand if fluspirilene inhibited CDK2 activities in hepatocellular carcinoma cells, we analyzed the effect of fluspirilene treatment with concentrations of 3, 10, 30 μM for 6, 12, 24 hours on cell cycle profile in HepG2 and Huh7 cells by flow cytometry (Fig 5).